Item 1.01. Entry into a Material Definitive Agreement
On June 17, 2009, HLTH Corporation and WebMD Health Corp. entered into an Agreement and Plan of Merger (the "Merger Agreement"). The Merger Agreement provides that HLTH will merge into WebMD, with WebMD continuing as the surviving company (the "Merger"). HLTH currently owns all 48.1 million outstanding shares of WebMD Class B Common Stock. The merger will eliminate both the controlling class of WebMD stock held by HLTH and WebMD's existing dual-class stock structure. In the merger, the WebMD Class B shares will be retired and each outstanding share of HLTH Common Stock will be converted into 0.4444 shares of WebMD Common Stock. Shares of WebMD Class A Common Stock will remain outstanding and will be unchanged in the merger. A copy of the press release announcing the Merger is filed as Exhibit 99.1 to this Current Report and is incorporated herein by reference.
The Merger Agreement contains customary representations, warranties and covenants that the parties made to each other, including, among others, covenants by each of HLTH and WebMD to conduct its business in the ordinary course between the signing of the Merger Agreement and completion of the Merger, and to maintain and preserve its business organizations and relationships during such period, except as contemplated by the Merger Agreement. A copy of the Merger Agreement is filed as Exhibit 2.1 to this Current Report in order to provide investors with information regarding the terms of the Merger Agreement and is not intended to be, and should not be relied upon as, disclosures regarding any facts and circumstances relating to HLTH or WebMD. The representations and warranties contained in the Merger Agreement have been negotiated with the principal purpose of establishing the circumstances in which either party may have the right not to consummate the Merger, or a party may have the right to terminate the Merger Agreement, if the representations and warranties of the other party prove to be untrue due to a change in circumstance or otherwise, and allocates risk between the parties, rather than establishing matters as facts. In addition, the representations and warranties contained in the Merger Agreement may also be subject to a contractual standard of materiality different from those generally applicable to investors. Additional Information About the Proposed Merger of HLTH and WebMD and Where to Find It:
In connection with the proposed Merger, HLTH and WebMD expect to file, with the SEC, a proxy statement/prospectus as part of a registration statement regarding the proposed transaction. Investors and security holders are urged to read the proxy statement/prospectus because it will contain important information about HLTH and WebMD and the proposed transaction. Investors and security holders may obtain a free copy of the definitive proxy statement/prospectus and other documents when filed by HLTH and WebMD with the SEC at www.sec.gov or www.hlth.com or www.wbmd.com. Investors and security holders are urged to read the proxy statement/prospectus and other relevant material when they become available before making any voting or investment decisions with respect to the Merger.

---

Participants in the Merger
HLTH, WebMD, their directors and certain of their executive officers may be considered participants in the solicitation of proxies in connection with the proposed transaction. Information about the directors and executive officers of HLTH and WebMD and their respective interests in the proposed transactions will be set forth or incorporated by reference in the proxy statement/prospectus that HLTH and WebMD will file with the SEC in connection with the proposed transaction. Information about the directors and executive officers of HLTH is available in Item 10 of HLTH's Annual Report on Form 10-K for the Year Ended December 31, 2008, included in an Amendment to that Form 10-K filed with the SEC on April 30, 2009. Information about the directors and executive officers of WebMD is available in Item 10 of WebMD's Annual Report on Form 10-K for the Year Ended December 31, 2008, included in an Amendment to that Form 10-K filed with the SEC on April 30, 2009. Investors may obtain additional information regarding the interests of such participants by reading the proxy statement/prospectus when it becomes available.
Item 9.01. Financial Statements and Exhibits

(d) Exhibits. The following exhibits are filed herewith:

Exhibit Number Description 2.1* Agreement and Plan of Merger, dated as of June 17, 2009, between HLTH Corporation and WebMD Health Corp. 99.1** Press Release, dated June 18, 2009, regarding the Merger

* The schedules to Exhibit 2.1 are omitted from this filing pursuant to Item 601(b)(2) of Regulation S-K. The Registrant will furnish copies of any of the omitted schedules to the Securities and Exchange Commission upon request.

** Previously
filed.

---